£91.00

Elsevier GERD: Reflux to Esophageal Adenocarcinoma

Price data last checked 48 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 43 days • 43 data points (No recent data available)

Historical
Generating forecast...
£91.00 £86.45 £88.27 £90.09 £91.91 £93.73 £95.55 25 January 2026 04 February 2026 15 February 2026 25 February 2026 08 March 2026

Price Distribution

Price distribution over 43 days • 1 price levels

Days at Price
43 days 0 11 22 32 43 £91 Days at Price

Price Analysis

Most common price: £91 (43 days, 100.0%)

Price range: £91 - £91

Price levels: 1 different prices over 43 days

Description

Gastroesophageal Reflux Disease (GERD) is one of the most common maladies of mankind. Approximately 40% of the adult population of the USA suffers from significant heartburn and the numerous antacids advertised incessantly on national television represents a $8 billion per year drug market. The ability to control acid secretion with the increasingly effective acid-suppressive agents such as the H2 blockers (pepcid, zantac) and proton pump inhibitors (nexium, prevacid) has given physicians an excellent method of treating the symptoms of acid reflux. Unfortunately, this has not eradicated reflux disease. It has just changed its nature. While heartburn, ulceration and strictures have become rare, reflux-induced adenocarcinoma of the esophagus is becoming increasingly common. Adenocarcinoma of the esophagus and gastric cardia is now the most rapidly increasing cancer type in the Western world. The increasing incidence of esophageal adenocarcinoma has created an enormous interest and stimulus for research in this area. GERD brings together a vast amount of disparate literature and presents the entire pathogenesis of reflux disease in one place. In addition to providing a new concept of how gastroesophageal reflux causes cellular changes in the esophagus, GERD also offers a complete solution to a problem that has confused physicians for over a century. Both clinical and pathological information about reflux disease and its treatment are presented. GERD is meant to be used as a comprehensive reference for gastroenterologists, esophageal surgeons, and pathologists alike. Outlines how gastroesophageal reflux causes cellular changes in the esophagus Brings together the pathogenesis of the disease in one source and applies it toward clinical treatment Tom DeMeester is THE leading international expert on reflux disease; Parakrama Chandrasoma is one of the leading pathologists in the area Book contains approximately 350 illustrations Ancillary web site features color illustrations: www.chandrasoma.com

Product Specifications

Format
Hardcover
Domain
Amazon UK
Release Date
23 October 2006
Listed Since
24 October 2006

Barcode

No barcode data available

Similar Products You Might Like

GERD: Reflux to Esophageal Adenocarcinoma
99% match

GERD: Reflux to Esophageal Adenocarcinoma

Elsevier

£84.00 28 Feb 2026
Academic Press - Diagnostic Atlas of GERD - Histology Method
96% match

Academic Press - Diagnostic Atlas of GERD - Histology Method

Academic Press

£119.26 26 Feb 2026
Springer - Gastroesophageal Reflux Disease Textbook
94% match

Springer - Gastroesophageal Reflux Disease Textbook

Springer

£108.78 06 Mar 2026
Multidisciplinary Management of Gastroesophageal Reflux Disease
93% match

Multidisciplinary Management of Gastroesophageal Reflux Disease

Springer

£87.11 27 Feb 2026
Gastroesophageal Reflux Disease (GERD): Clinical Characteristics, Management & Long-Term Outcomes
93% match

Gastroesophageal Reflux Disease (GERD): Clinical Characteristics, Management & Long-Term Outcomes

£78.99 04 Mar 2026
Reflux Disease: Causes, Symptoms and Treatment (Digestive Diseases - Research and Clinical Developments)
93% match

Reflux Disease: Causes, Symptoms and Treatment (Digestive Diseases - Research and Clinical Developments)

£15.51 05 Mar 2026
Revisiting Barrett's Esophagus
93% match

Revisiting Barrett's Esophagus

Springer

£72.65 26 Feb 2026
Failed Anti-Reflux Therapy: Analysis of Causes and Principles of Treatment
93% match

Failed Anti-Reflux Therapy: Analysis of Causes and Principles of Treatment

Springer

£68.90 04 Mar 2026
Adenocarcinoma of the Esophagogastric Junction: From Barrett's Esophagus to Cancer
93% match

Adenocarcinoma of the Esophagogastric Junction: From Barrett's Esophagus to Cancer

Springer

£80.64 01 Mar 2026
Gastric Cancer In The Precision Medicine Era: Diagnosis and Therapy (Current Clinical Pathology)
93% match

Gastric Cancer In The Precision Medicine Era: Diagnosis and Therapy (Current Clinical Pathology)

Humana

£88.34 01 Mar 2026
Effects, Diagnosis & Management of Extra-Esophageal Reflux (Digestive Diseases -- Research & Clinical Developments Series)
92% match

Effects, Diagnosis & Management of Extra-Esophageal Reflux (Digestive Diseases -- Research & Clinical Developments Series)

£97.48 06 Mar 2026
Gastroesophageal Reflux in Children
92% match

Gastroesophageal Reflux in Children

£23.62 13 Jan 2026
Gastric Cancer, An Issue of Gastroenterology Clinics (Volume 42-2) (The Clinics: Internal Medicine, Volume 42-2)
92% match

Gastric Cancer, An Issue of Gastroenterology Clinics (Volume 42-2) (The Clinics: Internal Medicine, Volume 42-2)

Elsevier

£53.98 16 Feb 2026
Esophageal Cancer: Prevention, Diagnosis and Therapy
92% match

Esophageal Cancer: Prevention, Diagnosis and Therapy

Springer

£93.19 10 Mar 2026
The Esophagus
92% match

The Esophagus

Wiley-Blackwell

£204.10 31 Jan 2026
Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions (Curbside Consultation in Gastroenterology)
92% match

Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions (Curbside Consultation in Gastroenterology)

Slack

£97.31 09 Mar 2026
Gastroesophageal Reflux in Children: GER in Children
92% match

Gastroesophageal Reflux in Children: GER in Children

Springer

£92.68 30 Mar 2026
Tumors of the Esophagus and Stomach (AFIP Atlas of Tumor Pathology, Series 4,): No. 28
92% match

Tumors of the Esophagus and Stomach (AFIP Atlas of Tumor Pathology, Series 4,): No. 28

£132.35 10 Mar 2026
Management of GERD, An Issue of Gastrointestinal Endoscopy Clinics: Volume 30-2 (The Clinics: Internal Medicine, Volume 30-2)
92% match

Management of GERD, An Issue of Gastrointestinal Endoscopy Clinics: Volume 30-2 (The Clinics: Internal Medicine, Volume 30-2)

Elsevier

£73.97 08 Mar 2026
Adenocarcinoma of the Esophagogastric Junction: 182 (Recent Results in Cancer Research, 182)
92% match

Adenocarcinoma of the Esophagogastric Junction: 182 (Recent Results in Cancer Research, 182)

Springer

£84.61 09 Mar 2026
Springer - Adenocarcinoma of the Esophagogastric Junction 182
92% match

Springer - Adenocarcinoma of the Esophagogastric Junction 182

Springer

£96.36 28 Feb 2026
Gastric Cancer: Risk Factors, Treatment & Clinical Outcomes
92% match

Gastric Cancer: Risk Factors, Treatment & Clinical Outcomes

£98.28 12 Jan 2026
Gastric Cardiac Cancer
92% match

Gastric Cardiac Cancer

Springer

£81.44 08 Mar 2026
Curbside Consultation in GERD: 49 Clinical Questions (Curbside Consultation in Gastroenterology)
92% match

Curbside Consultation in GERD: 49 Clinical Questions (Curbside Consultation in Gastroenterology)

Slack

£102.40 06 Mar 2026